Protalix Biotherapeutics, Inc. (PLX)
2.04
-0.01
(-0.49%)
USD |
NYAM |
Jan 21, 09:38
Protalix Biotherapeutics Free Cash Flow: -11.69M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| OraSure Technologies, Inc. | -43.65M |
| PAVmed, Inc. | -3.582M |
| Denali Therapeutics, Inc. | -410.85M |
| AIM ImmunoTech, Inc. | -13.33M |
| Armata Pharmaceuticals, Inc. | -27.43M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.732M |
| Cash from Investing (Quarterly) | -0.504M |
| Free Cash Flow Per Share (Quarterly) | -0.0523 |
| Free Cash Flow to Equity (Quarterly) | -7.058M |
| Free Cash Flow to Firm (Quarterly) | -4.041M |
| Free Cash Flow Yield | -7.29% |